Daily Messenger (Pakistan)
Patients with a deadly lung disease are three times as likely to experience severe coronary events - including heart attacks - than their normal counterparts, according to a recent study.
The study is based on an analysis of cardiovascular disease risk in nearly 1,000 patients with idiopathic pulmonary fibrosis (IPF) and more than 3,500 matched controls.
IPF is a disorder characterised by progressive scarring (fibrosis) and deterioration of the lungs.
"If you look at them over time, people with IPF have roughly a three-fold increased risk of acute coronary syndrome, which is a greater increase than you get from smoking," said
Hubbard and colleagues analysed data from the computerised records of the
In addition to having a markedly increased risk of heart problems, patients with IPF were 23 percent more likely to have angina, had a 60 percent higher risk of stroke, and a three-fold increased risk of deep vein thrombosis, according to Hubbard.
Notably, those with IPF were more than twice as likely as control subjects to have been prescribed amiodarone, a medication used for irregular heartbeats that has also been implicated as a cause of fibrotic lung disease.
This research could have serious implications for the 60,000 people with IPF who currently live in the US and the 21,000 people who receive this diagnosis for the first time each year, according to a
Unfortunately, medical knowledge about IPF is limited. "We know that genetic factors play some role in IPF because it clusters in families in about 10 percent of cases," said Hubbard.
Articles featured in Life Extension Daily News are derived from a variety of news sources and are provided as a service by Life Extension. These articles, while of potential interest to readers of Life Extension Daily News, do not necessarily represent the opinions nor constitute the advice of Life Extension.